Edna Chow Maneval
About Edna Chow Maneval
Edna Chow Maneval is a seasoned biopharmaceutical executive with extensive experience in oncology drug development.
Edna Chow Maneval Education and Expertise
Edna Chow Maneval holds a PhD in biomedical engineering from the University of Southern California. Her academic background laid a strong foundation for her career in clinical development and drug research. With her advanced knowledge and technical skillset, she has been able to contribute significantly to the field of biomedical sciences, especially in the areas of oncology and drug development.
Edna Chow Maneval Professional Title
Edna Chow Maneval is currently serving as the Senior Vice President of Clinical Development. In this role, she oversees various clinical programs and spearheads initiatives to develop new pharmaceutical therapies. Her leadership is integral to advancing clinical research and achieving successful outcomes for multiple drug development projects.
Edna Chow Maneval Career Background
Edna Chow Maneval began her career in drug development at Pfizer. During her tenure, she dedicated much of her time to the development and approval of sunitinib (SUTENT®), a medication used to treat cancer. Her career trajectory has demonstrated a consistent focus on oncology, leading to roles of increasing responsibility and influence in the pharmaceutical industry.
Edna Chow Maneval Achievements in Drug Development
Edna Chow Maneval has been the clinical lead for significant projects in cancer treatment. At Ignyta, she led the clinical development of entrectinib, a molecularly-targeted therapy for rare cancers affecting both adults and pediatric patients. Additionally, she has been responsible for the apalutamide (ERLEADA™) and SERD clinical programs focused on prostate and breast cancers at Aragon and Seragon. Her efforts in these projects have been pivotal in advancing cancer therapies.
Edna Chow Maneval Industry Recognition
Edna Chow Maneval has received industry recognition for her contributions to clinical development. Notably, she was honored as a YWCA TWIN (Tribute to Women & Industry) Honoree, highlighting her impact and leadership within the industry. This accolade acknowledges her dedication and achievements in her field.